UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Retreatment of patients who failed glecaprevir/pibrentasvir treatment for hepatitis C virus infection

Journal of hepatology, 2019-05, Vol.70 (5), p.1019-1023

2019

Volltextzugriff (PDF)

Comprehensive Analysis of Frequency and Phenotype of T Regulatory Cells in HIV Infection: CD39 Expression of FoxP3+ T Regulatory Cells Correlates with Progressive Disease

Journal of Virology, 2011-02, Vol.85 (3), p.1287-1297

2011

Volltextzugriff (PDF)

Effect of antiviral therapy for HCV on lipid levels

Antiviral therapy, 2017, Vol.21 (1), p.81-88

2017

Volltextzugriff (PDF)

Real‐world effectiveness of sofosbuvir‐based treatment regimens for chronic hepatitis C genotype 3 infection: Results from the multicenter German hepatitis C cohort (GECCO‐03)

Journal of medical virology, 2018-02, Vol.90 (2), p.304-312

2018

Volltextzugriff (PDF)

Age-related differences in response to peginterferon alfa-2a/ribavirin in patients with chronic hepatitis C infection

World journal of gastroenterology : WJG, 2014-08, Vol.20 (31), p.10984-10993

2014

Volltextzugriff (PDF)

Elevated liver enzymes predict morbidity and mortality despite antiviral cure in patients with chronic hepatitis C: Data from the German Hepatitis C‐Registry

Hepatology communications, 2022-09, Vol.6 (9), p.2488-2495

2022

Volltextzugriff (PDF)

Comparison of direct sequencing of the NS5B region with the Versant HCV genotype 2.0 assay for genotyping of viral isolates in Mexico

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2020-02, Vol.26 (2), p.205-210

2020

Volltextzugriff (PDF)

Chronic hepatitis C： Treat or wait？ Medical decision making in clinical practice

World journal of gastroenterology : WJG, 2012-03, Vol.18 (12), p.1339-1347

Claus Niederau Dietrich Huppe EImar Zehnter Bernd Moiler, Renate Heyne Stefan Christensen Rainer Waft Arno Theilmeier Ulrich Alshuth Stefan Mauss

2012

Volltextzugriff (PDF)

Renal impairment is frequent in chronic hepatitis C patients under triple therapy with telaprevir or boceprevir

Hepatology (Baltimore, Md.), 2014-01, Vol.59 (1), p.46-48

2014

Volltextzugriff (PDF)

A not so easy genotype—striking regional differences in SOF/RBV treatment responses in HCV GT2

Liver international, 2017-08, Vol.37 (8), p.1253-1254

2017

Volltextzugriff (PDF)

A not so easy genotype—striking regional differences in SOF / RBV treatment responses in HCV GT 2

Liver international, 2017-08, Vol.37 (8), p.1253-1254

2017

Volltextzugriff (PDF)

Drug-Drug Interactions in the Treatment of HCV Among People Who Inject Drugs

Clinical infectious diseases, 2013-08, Vol.57 (suppl_2), p.S125-S128

2013

Volltextzugriff (PDF)

Cystatin C as a marker of renal function is affected by HIV replication leading to an underestimation of kidney function in HIV patients

Antiviral therapy, 2008-01, Vol.13 (8), p.1091-1095

2008

Volltextzugriff (PDF)

Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients – FINITE study

Journal of hepatology, 2017-11, Vol.67 (5), p.918-924

2017

Volltextzugriff (PDF)

Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection

The New England journal of medicine, 2015-12, Vol.373 (27), p.2599-2607

2015

Volltextzugriff (PDF)

Wie wirken Generikaquoten? Eine Analyse am Beispiel der HIV-Infektion

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2021, Vol.64 (5), p.625-634

2021

Volltextzugriff (PDF)

Direct‐acting antiviral treatment of chronic HCV‐infected patients on opioid substitution therapy: Still a concern in clinical practice?

Addiction (Abingdon, England), 2018-05, Vol.113 (5), p.868-882

2018

Volltextzugriff (PDF)

THU-386-YI Renin-angiotensin inhibitor intake is associated with improved survival in patients with chronic hepatitis C viral infection following SVR-data from the german hepatitis C-registry (DHC-R)

Journal of hepatology, 2024-06, Vol.80, p.S820-S820

2024

Volltextzugriff (PDF)

Empfehlungen zur Hepatitis Versorgung bei Drogenkonsumierenden

The International journal of drug policy, 2023-01, Vol.111, Article 101670

2023

Volltextzugriff (PDF)

Reinfection With the Hepatitis C Virus in Men Who Have Sex With Men After Successful Treatment With Direct-acting Antivirals in Germany: Current Incidence Rates, Compared With Rates During the Interferon Era

Clinical infectious diseases, 2020-08, Vol.71 (5), p.1248-1254

2020

Volltextzugriff (PDF)

HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe

Journal of hepatology, 2017-02, Vol.66 (2), p.282-287

2017

Volltextzugriff (PDF)

Efficacy and Safety of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients With Chronic HCV Genotype 1 Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ION Trials

Clinical infectious diseases, 2016-12, Vol.63 (11), p.1405-1411

2016

Volltextzugriff (PDF)

Drug-Drug Interactions in the Treatment of HCV Among People Who Inject Drugs: Prevention and Management of Hepatitis C Virus Infection Among People Who Inject Drugs: Moving the Agenda Forward

Clinical infectious diseases, 2013, Vol.57

2013

Volltextzugriff (PDF)

Real-world treatment for chronic hepatitis C infection in Germany: Analyses from drug prescription data, 2010–2015

Journal of hepatology, 2017-07, Vol.67 (1), p.15-22

2017

Volltextzugriff (PDF)

Real-world effectiveness of 8-week treatment with ledipasvir/sofosbuvir in chronic hepatitis C

Journal of hepatology, 2018-04, Vol.68 (4), p.663-671

2018

Volltextzugriff (PDF)

1 – 25 von 185

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

KollektionSpringerLink (Online service)

KollektionThieme Connect Journals

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(173)

Publikationsform

Sprache

Englisch
(177)
Deutsch
(9)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(93)
Science & Technology
(93)
Humans
(84)
Male
(60)
Adult
(55)
Female
(55)
Middle Aged
(52)
Infectious Diseases
(50)
Antiviral Agents - Therapeutic Use
(42)
Gastroenterology & Hepatology
(41)
Hepatitis C
(35)
Gastroenterology And Hepatology
(34)
Hepatitis C, Chronic - Drug Therapy
(30)
Hepatitis
(29)
Aged
(26)
Hiv
(26)
Biological And Medical Sciences
(25)
Drug Therapy, Combination
(25)
Human Immunodeficiency Virus
(24)
Medical Sciences
(23)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Retreatment of patients who failed glecaprevir/pibrentasvir treatment for hepatitis C virus infection

Comprehensive Analysis of Frequency and Phenotype of T Regulatory Cells in HIV Infection: CD39 Expression of FoxP3+ T Regulatory Cells Correlates with Progressive Disease

Effect of antiviral therapy for HCV on lipid levels

Real‐world effectiveness of sofosbuvir‐based treatment regimens for chronic hepatitis C genotype 3 infection: Results from the multicenter German hepatitis C cohort (GECCO‐03)

Age-related differences in response to peginterferon alfa-2a/ribavirin in patients with chronic hepatitis C infection

Elevated liver enzymes predict morbidity and mortality despite antiviral cure in patients with chronic hepatitis C: Data from the German Hepatitis C‐Registry

Comparison of direct sequencing of the NS5B region with the Versant HCV genotype 2.0 assay for genotyping of viral isolates in Mexico

Chronic hepatitis C： Treat or wait？ Medical decision making in clinical practice

Renal impairment is frequent in chronic hepatitis C patients under triple therapy with telaprevir or boceprevir

A not so easy genotype—striking regional differences in SOF/RBV treatment responses in HCV GT2

A not so easy genotype—striking regional differences in SOF / RBV treatment responses in HCV GT 2

Drug-Drug Interactions in the Treatment of HCV Among People Who Inject Drugs

Cystatin C as a marker of renal function is affected by HIV replication leading to an underestimation of kidney function in HIV patients

Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients – FINITE study

Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection

Wie wirken Generikaquoten? Eine Analyse am Beispiel der HIV-Infektion

Direct‐acting antiviral treatment of chronic HCV‐infected patients on opioid substitution therapy: Still a concern in clinical practice?

THU-386-YI Renin-angiotensin inhibitor intake is associated with improved survival in patients with chronic hepatitis C viral infection following SVR-data from the german hepatitis C-registry (DHC-R)

Empfehlungen zur Hepatitis Versorgung bei Drogenkonsumierenden

Reinfection With the Hepatitis C Virus in Men Who Have Sex With Men After Successful Treatment With Direct-acting Antivirals in Germany: Current Incidence Rates, Compared With Rates During the Interferon Era

HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe

Efficacy and Safety of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients With Chronic HCV Genotype 1 Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ION Trials

Drug-Drug Interactions in the Treatment of HCV Among People Who Inject Drugs: Prevention and Management of Hepatitis C Virus Infection Among People Who Inject Drugs: Moving the Agenda Forward

Real-world treatment for chronic hepatitis C infection in Germany: Analyses from drug prescription data, 2010–2015

Real-world effectiveness of 8-week treatment with ledipasvir/sofosbuvir in chronic hepatitis C

Aktive Filter

Suchergebnisse filtern